Clearance is provided consistent with the understanding that the results of this study will not be represented as generalizable. The population served by the study site is not representative of the US population and the single health care system studied cannot be assumed to be representative of any particular provider model. Furthermore, as noted in the supporting statement, the internal(practice-based) sampling approach used is not suitable for drawing statistically rigorous comparisons. Rather, qualitative analysis will be used to gain insights into how, how well, and how easily different types of practices incorporate the system redesign intervention.
Inventory as of this Action
Requested
Previously Approved
12/31/2010
24 Months From Approved
9,877
0
0
2,047
0
0
0
0
0
The proposed study, Health Care Systems for Tracking Colorectal Cancer Screening Tests (contract number: HHSA290200600014, task order #1; task order number: 290-06-0014-1) is consistent with AHRQ's mission, as it will implement and assess a system redesign intervention to improve colorectal cancer (CRC) screening and follow-up among patients 50 - 79 years-old. The primary purpose of this study is to determine whether a system redesign intervention previously shown to be effective for increasing CRC screening and follow up rates in one setting can be successfully disseminated to other settings and to identify conditions and attributes associated with successful dissemination and uptake. This study will synthesize and disseminate information about appropriate CRC screening recommendations (that are consistent with 2008 American Cancer Society Guidelines) to both providers and patients at selected primary care practices. It will also provide a mechanism for facilitating CRC screening tests, monitoring the test results, informing providers of the results, and facilitating appropriate follow up through feedback to providers and subsequently patients. This in turn, is expected to help improve the quality of health care and its delivery. The study's analysis will determine to what extent this intervention was disseminated effectively and successfully and identify facilitators and barriers to effective and successful dissemination. It will also provide valuable information and "lessons learned" to other health care practices, delivery networks, and insurers that are interested in increasing CRC screening and follow up rates.
US Code:
42 USC 299
Name of Law: Healthcare Research and Quality Act of 1999
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.